The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma

ObjectiveMET positivity is independently associated with survival in oral squamous cell carcinoma (OSCC). Since MET is a known orchestrator of invasive tumor growth, we investigated its association with LNM in early oral tongue squamous cell carcinoma (OTSCC). As it is recommended by the NCCN to use...

Full description

Bibliographic Details
Main Authors: Maria J. De Herdt, Berdine van der Steen, Quincy M. van der Toom, Yassine Aaboubout, Stefan M. Willems, Marjan H. Wieringa, Robert J. Baatenburg de Jong, Leendert H. J. Looijenga, Senada Koljenović, Jose A. Hardillo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
MET
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.638048/full
id doaj-f8cd03c0fa7a4387b64bf1c90fc11262
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Maria J. De Herdt
Berdine van der Steen
Quincy M. van der Toom
Yassine Aaboubout
Yassine Aaboubout
Stefan M. Willems
Marjan H. Wieringa
Robert J. Baatenburg de Jong
Leendert H. J. Looijenga
Leendert H. J. Looijenga
Senada Koljenović
Jose A. Hardillo
spellingShingle Maria J. De Herdt
Berdine van der Steen
Quincy M. van der Toom
Yassine Aaboubout
Yassine Aaboubout
Stefan M. Willems
Marjan H. Wieringa
Robert J. Baatenburg de Jong
Leendert H. J. Looijenga
Leendert H. J. Looijenga
Senada Koljenović
Jose A. Hardillo
The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
Frontiers in Oncology
MET
occult lymph node metastasis
depth of invasion
oral tongue squamous cell carcinoma
elective neck dissection
author_facet Maria J. De Herdt
Berdine van der Steen
Quincy M. van der Toom
Yassine Aaboubout
Yassine Aaboubout
Stefan M. Willems
Marjan H. Wieringa
Robert J. Baatenburg de Jong
Leendert H. J. Looijenga
Leendert H. J. Looijenga
Senada Koljenović
Jose A. Hardillo
author_sort Maria J. De Herdt
title The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
title_short The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
title_full The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
title_fullStr The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
title_full_unstemmed The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
title_sort potential of met immunoreactivity for prediction of lymph node metastasis in early oral tongue squamous cell carcinoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-04-01
description ObjectiveMET positivity is independently associated with survival in oral squamous cell carcinoma (OSCC). Since MET is a known orchestrator of invasive tumor growth, we investigated its association with LNM in early oral tongue squamous cell carcinoma (OTSCC). As it is recommended by the NCCN to use tumor depth of invasion (DOI) in making decisions on elective neck dissection (END), the results obtained for MET positivity were aligned with those for DOI > 4 mm. The cutoff value used in our institution.MethodsTumor samples from patients who underwent primary tumor resection and neck dissection between 1995 and 2013, were collected from the archives of the Leiden and Erasmus University Medical Center. Immunohistochemistry with D1C2 was performed to identify MET negative (< 10% uniform positivity) and MET positive (≥ 10% uniform positivity) cancers. ROC curve analysis and the Chi-squared test were used to investigate the association of MET positivity with LNM (pN+ and occult). Binary logistic regression was used to investigate the association of MET positivity with LNM.ResultsForty-five (44.1%) of the 102 cancers were MET positive. Ninety were cN0 of which 20 were pN+ (occult metastasis). The remaining 12 cancers were cN+, of which 10 were proven pN+ and 2 were pN0. MET positivity was associated with LNM with a positive predictive value (PPV) of 44.4% and a negative predictive value (NPV) of 82.5% for pN+. For the occult group, the PPV was 36.8% and the NPV was 88.5%. Regression analysis showed that MET positivity is associated with pN+ and occult LNM (p-value < 0.05).ConclusionMET positivity is significantly associated with LNM in early OTSCC, outperforming DOI. The added value of MET positivity could be in the preoperative setting when END is being considered during the initial surgery. For cases with DOI ≤ 4 mm, MET positivity could aid in the clinical decision whether regular follow-up, watchful waiting, or END is more appropriate. Realizing that these preliminary results need to be independently validated in a larger patient cohort, we believe that MET positivity could be of added value in the decision making on END in early OTSCC.
topic MET
occult lymph node metastasis
depth of invasion
oral tongue squamous cell carcinoma
elective neck dissection
url https://www.frontiersin.org/articles/10.3389/fonc.2021.638048/full
work_keys_str_mv AT mariajdeherdt thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT berdinevandersteen thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT quincymvandertoom thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT yassineaaboubout thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT yassineaaboubout thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT stefanmwillems thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT marjanhwieringa thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT robertjbaatenburgdejong thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT leenderthjlooijenga thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT leenderthjlooijenga thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT senadakoljenovic thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT joseahardillo thepotentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT mariajdeherdt potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT berdinevandersteen potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT quincymvandertoom potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT yassineaaboubout potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT yassineaaboubout potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT stefanmwillems potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT marjanhwieringa potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT robertjbaatenburgdejong potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT leenderthjlooijenga potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT leenderthjlooijenga potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT senadakoljenovic potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
AT joseahardillo potentialofmetimmunoreactivityforpredictionoflymphnodemetastasisinearlyoraltonguesquamouscellcarcinoma
_version_ 1721501343834701824
spelling doaj-f8cd03c0fa7a4387b64bf1c90fc112622021-04-29T10:57:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-04-011110.3389/fonc.2021.638048638048The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell CarcinomaMaria J. De Herdt0Berdine van der Steen1Quincy M. van der Toom2Yassine Aaboubout3Yassine Aaboubout4Stefan M. Willems5Marjan H. Wieringa6Robert J. Baatenburg de Jong7Leendert H. J. Looijenga8Leendert H. J. Looijenga9Senada Koljenović10Jose A. Hardillo11Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology and Medical Biology, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology, University Medical Center Groningen, Groningen, NetherlandsDepartment of Education, Office of Science, Elisabeth TweeSteden, Ziekenhuis, Tilburg, NetherlandsDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology and Medical Biology, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsPrincess Maxima Center for Pediatric Oncology, Utrecht, NetherlandsDepartment of Pathology and Medical Biology, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC, University Medical Center Rotterdam, Cancer Institute, Rotterdam, NetherlandsObjectiveMET positivity is independently associated with survival in oral squamous cell carcinoma (OSCC). Since MET is a known orchestrator of invasive tumor growth, we investigated its association with LNM in early oral tongue squamous cell carcinoma (OTSCC). As it is recommended by the NCCN to use tumor depth of invasion (DOI) in making decisions on elective neck dissection (END), the results obtained for MET positivity were aligned with those for DOI > 4 mm. The cutoff value used in our institution.MethodsTumor samples from patients who underwent primary tumor resection and neck dissection between 1995 and 2013, were collected from the archives of the Leiden and Erasmus University Medical Center. Immunohistochemistry with D1C2 was performed to identify MET negative (< 10% uniform positivity) and MET positive (≥ 10% uniform positivity) cancers. ROC curve analysis and the Chi-squared test were used to investigate the association of MET positivity with LNM (pN+ and occult). Binary logistic regression was used to investigate the association of MET positivity with LNM.ResultsForty-five (44.1%) of the 102 cancers were MET positive. Ninety were cN0 of which 20 were pN+ (occult metastasis). The remaining 12 cancers were cN+, of which 10 were proven pN+ and 2 were pN0. MET positivity was associated with LNM with a positive predictive value (PPV) of 44.4% and a negative predictive value (NPV) of 82.5% for pN+. For the occult group, the PPV was 36.8% and the NPV was 88.5%. Regression analysis showed that MET positivity is associated with pN+ and occult LNM (p-value < 0.05).ConclusionMET positivity is significantly associated with LNM in early OTSCC, outperforming DOI. The added value of MET positivity could be in the preoperative setting when END is being considered during the initial surgery. For cases with DOI ≤ 4 mm, MET positivity could aid in the clinical decision whether regular follow-up, watchful waiting, or END is more appropriate. Realizing that these preliminary results need to be independently validated in a larger patient cohort, we believe that MET positivity could be of added value in the decision making on END in early OTSCC.https://www.frontiersin.org/articles/10.3389/fonc.2021.638048/fullMEToccult lymph node metastasisdepth of invasionoral tongue squamous cell carcinomaelective neck dissection